Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea-Reference-Cited by-同舟云学术

Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea

Published:2019-02-11 Issue:6 Volume:91 Page:1104-1111
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Kwon Jung Hyun¹²^ORCID,Yoo Sun Hong¹²,Nam Soon Woo¹²,Kim Hee Yeon³²,Kim Chang Wook³²,You Chan Ran⁴²,Choi Sang Wook⁴²,Cho Se Hyun⁵²,Han Joon‐Yeol⁵²,Song Do Seon⁶²,Chang U Im⁶²,Yang Jin Mo⁶²,Lee Sung Won⁷²,Lee Hae Lim⁷²,Han Nam Ik⁷²,Kim Seok‐Hwan⁸²,Song Myeong Jun⁸²,Sung Pil Soo⁹²,Jang Jeong Won⁹²,Bae Si Hyun⁹²,Choi Jong Young⁹²,Yoon Seung Kew⁹²^ORCID

Affiliation:

1. Department of Internal MedicineIncheon St. Mary's Hospital, College of Medicine, The Catholic University of KoreaIncheon Republic of Korea

2. The Catholic University Liver Research Center, College of Medicine, The Catholic University of KoreaSeoul Republic of Korea

3. Department of Internal MedicineUijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu Republic of Korea

4. Department of Internal MedicineSt. Paul's Hospital, College of Medicine, The Catholic University of KoreaSeoul Republic of Korea

5. Department of Internal MedicineYeouido St. Mary's Hospital, College of Medicine, The Catholic University of KoreaSeoul Republic of Korea

6. Department of Internal MedicineSt.Vincent's Hospital, College of Medicine, The Catholic University of KoreaSuwon Republic of Korea

7. Department of Internal MedicineBucheon St. Mary's Hospital, College of Medicine, The Catholic University of KoreaBucheon Republic of Korea

8. Department of Internal MedicineDaejeon St. Mary's Hospital, College of Medicine, The Catholic University of KoreaDaejeon Republic of Korea

9. Department of Internal MedicineSeoul St. Mary's Hospital, College of Medicine, The Catholic University of KoreaSeoul Republic of Korea

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25412

Reference32 articles.

1. Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

3. Outcome of sustained virological responders with histologically advanced chronic hepatitis C

4. Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study;The Korean Journal of Internal Medicine;2023-07-01

2. Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea;Clinical and Molecular Hepatology;2023-04-01

3. The Incidence and Care Cascade of the Hepatitis C Virus in Korea;Gut and Liver;2023-03-02

4. Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection;The Egyptian Journal of Internal Medicine;2022-02-11

5. A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective;Clinical and Molecular Hepatology;2022-01-01